Walsh Patrick D
SEC Form 4 insider trading activity
Walsh Patrick D has filed 3 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: May 14, 2026.
On the most recent filing, Walsh Patrick D is listed as Director at ANI PHARMACEUTICALS INC. Inside the rolling window, Walsh Patrick D reported no open-market purchases and 4 open-market sales totaling $2.3M in ANIP. The largest disclosed transaction in the window is a sale of 10,000 ANIP shares on May 13, 2026, worth $806K.
Companies traded
Other insiders at ANIP
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$2.3M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Walsh Patrick D made?
Walsh Patrick D has filed 3 SEC Form 4 filings (5 transaction rows) across 1 company since 2025.
Which companies does Walsh Patrick D trade?
Walsh Patrick D has filed SEC Form 4 disclosures for 1 company, including ANIP.
When was Walsh Patrick D's most recent SEC Form 4 filing?
Walsh Patrick D's most recent SEC Form 4 filing on Tracefour is dated May 14, 2026.
What is Walsh Patrick D's total buy and sell value in the current window?
Inside the rolling retention window, Walsh Patrick D bought $0 and sold $2.3M based on SEC Form 4 filings.
What was Walsh Patrick D's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 10,000 ANIP shares on 2026-05-13, worth $806K, per SEC Form 4 filings.